Publications by authors named "Naghmeh Niktoreh"

Claim this Profile
I
Improved outcomes and treatment guidance in pediatric therapy-related AML: AML-BFM study group recommendations.
Stephanie Sendker, Markus Schneider, Evangelia Antoniou, Daniel Neumann, Naghmeh Niktoreh

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysis.
Evangelia Antoniou, Annika Puschnig, Naghmeh Niktoreh, Lina Marie Hoffmeister, Markus Schneider

EClinicalMedicine· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Selim Corbacioglu, Holger Lode, Susanne Ellinger, Florian Zeman, Meinolf Suttorp, Naghmeh Niktoreh

Lancet Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.
Stephanie Sendker, Amani Awada, Sophia Domagalla, Michael Sendker, Eser Orhan, Naghmeh Niktoreh

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Alterations and Expression Profiles in Hematological Malignancies.
Naghmeh Niktoreh, Lisa Weber, Christiane Walter, Mahshad Karimifard, Lina Marie Hoffmeister

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies.
Maren Soldierer, Arthur Bister, Corinna Haist, Aniththa Thivakaran, Sevgi Can Cengiz, Naghmeh Niktoreh

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia.
Lina Marie Hoffmeister, Eser Orhan, Christiane Walter, Naghmeh Niktoreh, Helmut Hanenberg

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.
Mareike Rasche, Martin Zimmermann, Emma Steidel, Todd Alonzo, Richard Aplenc, Naghmeh Niktoreh

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redirecting the Immune Microenvironment in Acute Myeloid Leukemia.
Stephanie Sendker, Dirk Reinhardt, Naghmeh Niktoreh

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group.
Mareike Rasche, Emma Steidel, Martin Zimmermann, Jean-Pierre Bourquin, Heidrun Boztug, Naghmeh Niktoreh

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutated , and Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia.
Naghmeh Niktoreh, Christiane Walter, Martin Zimmermann, Christine von Neuhoff, Nils von Neuhoff

J Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group.
Naghmeh Niktoreh, Beate Lerius, Martin Zimmermann, Bernd Gruhn, Gabriele Escherich

Haematologica· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis